As of 30 Sep 2025, 36 institutional investors reported holding $451,248,130 in principal (par value) of TRANSMEDICS GROUP INC - NOTE 1.500% 6/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $460 | $693,000 | 150652.17% | 1 | |
| 2025 Q3 | $451,248,130 | $642,136,626 | -$20,192,762 | 141.96% | 36 |
| 2025 Q2 | $484,153,790 | $776,802,093 | +$65,611,284 | 160.45% | 39 |
| 2025 Q1 | $454,412,980 | $490,019,942 | -$5,734,212 | 107.56% | 43 |
| 2024 Q4 | $455,514,950 | $471,588,260 | -$50,686,558 | 103.14% | 46 |
| 2024 Q3 | $466,705,600 | $862,026,492 | +$28,873,840 | 184.51% | 47 |
| 2024 Q2 | $452,711,000 | $796,245,316 | +$786,600,070 | 175.55% | 39 |